Fritextsökning
Innehållstyper
-
Medicult disclaims Swedish offer
The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.
-
Fortsatt högtryck i svensk export
Fortsatt positiv syn på exporten bland svenska företag visar Business Swedens färska siffror.
-
Rosling-kurs på KI för alla
Nu finns en online-kurs i global hälsa baserad på Hans Roslings kunskaper och metoder. Kursen vid KI är öppen för alla.
-
Slutar söka patent i låginkomstländer
- I lågutvecklade och låginkomstländer kommer vi från och med nu inte att söka patent alls. I fattigare medelinkomstländer kommer vi att söka patent men även ge...
-
Biogaia's advance goes on
In December Biogaia reached China and North America. Now, the Swedish probiotic company has entered the Mexican market.
-
Vattenfall is firing with biomass
Vattenfall will provide Denmark with electricity by means of biomass.
-
Rapid and thorough homogenization of samples
MP Biomedicals presents the Fasprep-24 instrument, a new high-throughput model of the earlier Bio 101 Systems Fastprep homogenizer.
-
Sverige i innovationstoppen
Sverige är världens tredje innovativa land enligt Bloomberg Innovation Index
-
Ten recieve the Venture Cup West Prize
At this year´s Venture Cup West awards the 10 best business ideas in Venture Cup West 08/09 were chosen, receiving SEK 10 000 each.
-
Biosimilarer ger prispress, men används de tillräckligt?
Biosimilarernas ankomst för drygt 16 år sedan väckte hopp om att många fler patienter skulle få tillgång till effektiva men annars mycket dyra behandlingar med ...
-
Collaboration brings next generation drugs
Wyeth and Santaris Pharma announce a new alliance to develop RNA-based medicines.
-
Snart faller klubban för Astrazeneca
I dag torsdag hålls slutpläderingarna i det första pay-for-delay-fallet i USA, som kan ge läkemedelsbolaget miljarder dollar i böter.
-
Age essential when testing drugs
Anders Rane has been arguing that genes and age are both important factors in understanding how medicines affect individuals. Only last year, the EU established...
-
Symphogen buys tumor blocking technology
The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...
-
Neurovive inleder fas II-studie
Första patienten rekryterad till studien Ciprics, på akut njurskada vid hjärtkirurgi.
-
Re-painting the big pig-ture
Why do tame pigs show such variety in colouring, when their wild relatives are so plain? Swedish researchers know who is to blame. But the big question is why.
-
Printing sensors for biological samples
Acreo develops technologies for printed electronics. Using organic printers, Acreo can print a transistor where biological samples can be placed.
-
Platelet analysis in whole blood
The new Multiplate analyzer from Triolab uses impedance aggregometry to measure the effects of platelet inhibitors on whole blood.
-
KI Innovations säljer projekt
Smartwise köper medtechprojektet Extroducer.
-
First ever study of human stem cell treatment
The FDA says yes to the world's first study in man of a human embryonic stem cell based therapy to treat spinal injury.
-
Danish biorefinery can save US billions
The Danish Inbicon biorefinery process could save the US billions on foreign oil, the organization states.
-
Measure blood sugar without finger pricking
The Danish entrepreneurial firm RSP Systems has developed a method to measure the blood sugar level in diabetes patients, simply by placing a fingertip on a sma...
-
Lytix calls in cash
Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.
-
Cykel till Silviahemmet
Brighter inleder samarbete med Silviahemmet genom att erbjuda sin innovation jDome BikeAround till demenshemmets patienter.